In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Anavex Life Sciences (AVXL - Research Report), with a price target of $40.00. The company's shares closed yesterday at $11.67.According to TipRanks, Palomeque is an analyst with an average return of -14.5% and a 32.67% success rate. Palomeque covers the Healthcare sector, focusing on stocks such as Anavex Life Sciences, RegenXBio, and Denali Therapeutics.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Anavex Life Sciences with a $35.20 average price target, a 201.63% upside from current levels. In a report released yesterday, H.C.
https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-gets-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Anavex Life Sciences Charts.